OSLO—Norway will not resume use of the COVID-19 vaccine made by AstraZeneca, and a decision on whether to include Johnson & Johnson shots in its mass inoculation scheme remains on hold, Prime Minister Erna Solberg said on Wednesday.
A government-appointed commission had recommended that both vaccines be excluded from Norway’s program due to the risk of rare but harmful side effects.
